About check-cap - CHEK
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule systems for colorectal cancer screening. Its patented technology, C-Scan, is a patient-friendly preparation-free test designed to detect polyps before they may transform into cancer. The company was founded by Yoav Kimchy in 2005 and is headquartered in Isfiya, Israel.
CHEK At a Glance
Check-Cap Ltd.
29 Abba Hushi Avenue
Isfiya, Haifa 3009000
| Phone | 972-52-777-2073 | Revenue | 0.00 | |
| Industry | Medical Specialties | Net Income | -17,568,000.00 | |
| Sector | Health Technology | Employees | N/A | |
| Fiscal Year-end | 12 / 2024 | |||
| View SEC Filings |
CHEK Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | 0.514 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 0.713 |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | N/A |
CHEK Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | N/A |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
CHEK Liquidity
| Current Ratio | 18.689 |
| Quick Ratio | 18.689 |
| Cash Ratio | 18.614 |
CHEK Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -49.868 |
| Return on Equity | -54.056 |
| Return on Total Capital | -74.167 |
| Return on Invested Capital | -53.54 |
CHEK Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | N/A |
| Total Debt to Total Assets | N/A |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |